Test 3 SCD & CF Flashcards

1
Q

causation of SCD

A

Caused by a mis-sense mutation in the 6th codon of the beta chain of Hemoglobin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the most common form of SCD?

A

Hb SS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

SCD: mutation

A
  • glutamate converted into valine on the 6th codon
  • Glu is hydrophilic
  • Val is hydrophobic
  • causes insoluble rod-like clumps
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

SCD: what does the hydrophobic surface cause?

A

polymerization of deoxyhemoglobin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

consequences of SCD

A
  • Pain crises
  • Chronic pain
  • Severe anemia
  • Infections
  • Spleen sequestration
  • Gall stones
  • Priapism
  • Brain stroke
  • Silent Brain injury
  • Organ failure (including eyes & blindness)
  • Acute Chest syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

initial symptoms of SCD

A
  • Dactylitis: swelling of hands & feet
  • Fatigue, fussiness
  • Yellowish skin (jaundice)
  • Yellowish eyes (icteris)
  • Shortness of breath
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

diagnostic tests: SCD

A
  • prenatal: test amniotic fluid or tissue from placenta
  • newborn test: 5-40 day old
  • filter paper test: clot = positive for SCD
  • Gel Electrophoresis - HbA will run deeper in the gel b/c it’s more negative
  • PCR & restriction enzyme digestion: look @ notes for visual sl19
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

SCD therapy

A
  • treat symptoms: pain, anemia, infections
  • hydroxyurea increases fetal Hb (protects against HbS side effects)
  • cure: myeloablative Hematopoietic Stem Cell Transplantation
  • CRISPR/Cas 9: edit stem cell to have HbA gene and engraft in bone marrow
  • Voxelotor: increases Hb’s affinity to O2
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

CF: mutation

A

various mutations in the CFTR gene -> encodes a chloride ion channel that regulates salt and water movement in cells -> thick, sticky mucus and salty sweat

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

most common CF mutation in US

A

3-base pair deletion ∆F508 or Phe508del -> loss of Phenylalanine at position 508 of the protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

initial symptoms of CF

A
  • salty skin
  • baby doesn’t pass stool
  • frequent coughing
  • thick sputum / bloody
  • abd discomfort / pain
  • large, greasy stools
  • poor weight gain and growth
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

consequences of CF

A
  • blocked airways -> trouble breathing
  • mucus in airways -> infections
  • Pneumothorax & bronchiectasis
  • Blocked pancreas -> no digestive enzymes -> constipation, dehydration
  • Salty sweat -> dehydration, increased heart rate, heat stroke, ↓ BP
  • ↑ risk for diabetes
  • osteoporosis, osteopenia, clubbing
  • infertility
  • respiratory failure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

diagnostic tests: CF

A
  • newborn heel prick: genetic test and pancreatic function test
  • sweat test: topical pilocarpine applied to skin, electrical current induces sweating, sweat collected, measure for Cl content, 30, 30-59, 60 mEq/L
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

CF therapy

A
  • antibiotics
  • nebulizers
  • bronchodilators
  • chest physical therapy
  • pancreatic enzyme
  • vitamins
  • increased fluid consumption
  • Ivacaftor (Kalydeco®)
  • Lumacaftor/Ivacaftor (Orkambi ®)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Ivacaftor (Kalydeco®)

A
  • CFTR conductance potentiator
  • For patients > 6 yrs of age with select mutation G551D
  • Improves lung function & increases weight
  • Reduces exacerbations by 25-50%
  • Oral administration – every 12 hrs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Lumacaftor/Ivacaftor (Orkambi ®)

A
  • potentiator (Ivacaftor): improves channel function
  • corrector (Lumacaftor): improves processing and trafficking to surface of apical cell membrane
  • For patients > 12 yrs of age with homozygous ∆F508
  • Oral administration – every 12 hrs